Literature DB >> 6468868

Plasma cysteine, cystine, and glutathione in cirrhosis.

R K Chawla, F W Lewis, M H Kutner, D M Bate, R G Roy, D Rudman.   

Abstract

Plasma contains three forms of cyst(e)ine: cysteine, cystine, and protein-bound cysteine. The former is a thiol and the latter two are disulfides. The levels of all three types of cyst(e)ine, as well as the cysteinyl tripeptide glutathione, were measured in the plasma of 14 normal and 10 cirrhotic individuals. All subjects ate mixed foods. Some cirrhotic patients were studied during nasogastric hyperalimentation with Vivonex (Norwich Eaton Pharmaceuticals, Norwich, N.Y.) as well as during total parenteral nutrition with FreAmine III (American McGaw, Irvine, Calif.); neither formula contains cyst(e)ine. Regardless of the nature of the diet, cirrhotic patients had significantly subnormal values for cysteine, glutathione, and albumin. In addition, the following significant changes were found to be diet-dependent: (a) elevated methionine during Vivonex, (b) subnormal taurine during mixed foods and total parenteral nutrition, (c) depressed protein-bound cysteine during total parenteral nutrition, (d) depressed cyst(e)ine thiol/disulfide ratio during mixed foods, and (e) depressed total thiol during Vivonex and total parenteral nutrition. The data indicate multiple abnormalities in sulfur metabolism in cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6468868

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  33 in total

Review 1.  Histone modifications and alcohol-induced liver disease: are altered nutrients the missing link?

Authors:  Akshata Moghe; Swati Joshi-Barve; Smita Ghare; Leila Gobejishvili; Irina Kirpich; Craig J McClain; Shirish Barve
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

Review 2.  Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part I. Biochemical implications.

Authors:  J M Mato; F Corrales; A Martin-Duce; P Ortiz; M A Pajares; C Cabrero
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 3.  Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease.

Authors:  R K Chawla; H L Bonkovsky; J T Galambos
Journal:  Drugs       Date:  1990       Impact factor: 9.546

4.  Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma.

Authors:  H P Eck; P Drings; W Dröge
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

5.  The Ubiquitin Binding Protein TAX1BP1 Mediates Autophagasome Induction and the Metabolic Transition of Activated T Cells.

Authors:  Michael I Whang; Rita M Tavares; Daniel I Benjamin; Michael G Kattah; Rommel Advincula; Daniel K Nomura; Jayanta Debnath; Barbara A Malynn; Averil Ma
Journal:  Immunity       Date:  2017-03-14       Impact factor: 31.745

6.  [The use of different cysteine derivatives in longterm parenteral nutrition].

Authors:  S Böhler; M Neuhäuser-Berthold
Journal:  Z Ernahrungswiss       Date:  1989-03

Review 7.  The use of selected nutrition supplements and complementary and alternative medicine in liver disease.

Authors:  A James Hanje; Brett Fortune; Ming Song; Daniell Hill; Craig McClain
Journal:  Nutr Clin Pract       Date:  2006-06       Impact factor: 3.080

8.  Methylmercury toxicity and Nrf2-dependent detoxification in astrocytes.

Authors:  Ling Wang; Haiyan Jiang; Zhaobao Yin; Michael Aschner; Jiyang Cai
Journal:  Toxicol Sci       Date:  2008-09-23       Impact factor: 4.849

9.  [A cystine-containing short-chain peptide as a potential cystine source for parenteral nutrition].

Authors:  L Pollack; P Stehle; S Albers; P Fürst
Journal:  Z Ernahrungswiss       Date:  1989-09

Review 10.  Thiol/disulfide redox states in signaling and sensing.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-01-29       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.